These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 23083098)

  • 21. Proniosomes: the effective and efficient drug-carrier system.
    Mittal S; Chaudhary A; Chaudhary A; Kumar A
    Ther Deliv; 2020 Feb; 11(2):125-137. PubMed ID: 31937205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sorbitan monopalmitate-based proniosomes for transdermal delivery of chlorpheniramine maleate.
    Varshosaz J; Pardakhty A; Baharanchi SM
    Drug Deliv; 2005; 12(2):75-82. PubMed ID: 15824032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and evaluation of nanosized niosomal dispersion for oral delivery of Ganciclovir.
    Akhter S; Kushwaha S; Warsi MH; Anwar M; Ahmad MZ; Ahmad I; Talegaonkar S; Khan ZI; Khar RK; Ahmad FJ
    Drug Dev Ind Pharm; 2012 Jan; 38(1):84-92. PubMed ID: 21726136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue distribution, pharmacokinetics and stability studies of zidovudine delivered by niosomes and proniosomes.
    Ruckmani K; Sankar V; Sivakumar M
    J Biomed Nanotechnol; 2010 Feb; 6(1):43-51. PubMed ID: 20499831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of formulation compositions on niosomal preparations.
    Chaw CS; Kim KY
    Pharm Dev Technol; 2013; 18(3):667-72. PubMed ID: 22468904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro and in vivo evaluation of Bola-surfactant containing niosomes for transdermal delivery.
    Paolino D; Muzzalupo R; Ricciardi A; Celia C; Picci N; Fresta M
    Biomed Microdevices; 2007 Aug; 9(4):421-33. PubMed ID: 17252206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proniosomal transdermal therapeutic system of losartan potassium: development and pharmacokinetic evaluation.
    Thakur R; Anwer MK; Shams MS; Ali A; Khar RK; Shakeel F; Taha EI
    J Drug Target; 2009 Jul; 17(6):442-9. PubMed ID: 19527115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation and characterization of niosomes containing ribavirin for liver targeting.
    Hashim F; El-Ridy M; Nasr M; Abdallah Y
    Drug Deliv; 2010 Jul; 17(5):282-7. PubMed ID: 20350052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on biological macromolecules lipid-Gelucire based gastroretentive multiparticulate.
    Upadhyay P; Pandit JK; Wahi AK
    Int J Biol Macromol; 2014 Jun; 67():463-77. PubMed ID: 24699418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Niosomes vs microemulsions: new carriers for topical delivery of Capsaicin.
    Tavano L; Alfano P; Muzzalupo R; de Cindio B
    Colloids Surf B Biointerfaces; 2011 Oct; 87(2):333-9. PubMed ID: 21684725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of surfactants on the characteristics of fluconazole niosomes for enhanced cutaneous delivery.
    Gupta M; Vaidya B; Mishra N; Vyas SP
    Artif Cells Blood Substit Immobil Biotechnol; 2011 Dec; 39(6):376-84. PubMed ID: 21951195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resveratrol proniosomes as a convenient nanoingredient for functional food.
    Schlich M; Lai F; Pireddu R; Pini E; Ailuno G; Fadda AM; Valenti D; Sinico C
    Food Chem; 2020 Apr; 310():125950. PubMed ID: 31830712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and evaluation of proniosomes as a carrier for ocular delivery of lomefloxacin HCl.
    Khalil RM; Abdelbary GA; Basha M; Awad GE; El-Hashemy HA
    J Liposome Res; 2017 Jun; 27(2):118-129. PubMed ID: 27079800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proniosomes derived niosomes: recent advancements in drug delivery and targeting.
    Khatoon M; Shah KU; Din FU; Shah SU; Rehman AU; Dilawar N; Khan AN
    Drug Deliv; 2017; 24(sup1):56-69. PubMed ID: 29130758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Niosomes in sustained and targeted drug delivery: some recent advances.
    Azeem A; Anwer MK; Talegaonkar S
    J Drug Target; 2009 Nov; 17(9):671-89. PubMed ID: 19845484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and characterization of effective topical liposomal system for localized treatment of cutaneous candidiasis.
    Gupta M; Goyal AK; Paliwal SR; Paliwal R; Mishra N; Vaidya B; Dube D; Jain SK; Vyas SP
    J Liposome Res; 2010 Dec; 20(4):341-50. PubMed ID: 20163329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation of quercetin and rutin-loaded ceramide liposomes and drug-releasing effect in liposome-in-hydrogel complex system.
    Park SN; Lee MH; Kim SJ; Yu ER
    Biochem Biophys Res Commun; 2013 Jun; 435(3):361-6. PubMed ID: 23669037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of gelucire content on stability, macrophage interaction and blood circulation of nanoparticles engineered from nanoemulsions.
    Wehrung D; Geldenhuys WJ; Oyewumi MO
    Colloids Surf B Biointerfaces; 2012 Jun; 94():259-65. PubMed ID: 22386863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An evaluation of the mechanisms of drug release from glyceride bases.
    Sutananta W; Craig DQ; Newton JM
    J Pharm Pharmacol; 1995 Mar; 47(3):182-7. PubMed ID: 7602477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Review on Proniosomes: A Propitious Outlook to the Provesicular Drug Delivery System.
    Saxena A; Apurvi P; Aslam R
    Curr Drug Deliv; 2023; 20(8):1115-1126. PubMed ID: 36278459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.